Studying the Efficacy of Vazonat in Comprehensive Treatment of Patients with Diabetes Mellitus Type 2

Abstract

The objective — ​to study the effectiveness of Vazonat (meldonium) in patients with diabetes mellitus (DM) type 2 in the comparative 12-week study. Materials and methods. The study involved 55 patients with DM type 2. Patients of the first group in addition to the basic treatment for DM received meldonium (Vazonat, OlainFarm JSC, Latvia) at a dose of 1000 mg/day during 12 weeks. The second group included 25 patients with DM type 2 (8 men and 17 women, average age 60.4 ± 1.9 years), who received only basic therapy of DM. Results. 12-week meldonium therapy as a part of combination therapy for DM type 2 statistically significantly improves the performance of kidney function, as indicated by a significant reduction in the level of microalbuminuria, creatinine and increased glomerular filtration rate in the first group of patients. Inclusion in the treatment regimen of Vazonat in patients with type 2 DM improves morphofunctional parameters of the heart, has additional nephroprotective action, reduces the average values of triglycerides and low-density lipoproteins, as well as glycated hemoglobin levels compared to baseline therapy. Conclusions. Vazonat, combining cardioprotective properties and hypoglycemic effect, is a particularly good choice for comprehensive treatment of patients with impaired glucose metabolism, diabetic nephropathy and heart failure.

Authors and Affiliations

V. I. Pankivn

Keywords

Related Articles

Assessment of somatotropic function in children with syndrome of biologically inactive growth hormone against a background of clonidine and insulin stimulation tests

Background. Growth pathology caused by somatotropic insufficiency is one of the most urgent problems in pediatric endocrinology. An increase in the growth hormone (GH) level less than 10 ng/ml was traditio­nally consider...

Effect of Pro197Leu Polymorphism of the Gene GPX1 on Carbohydrate Metabolism and Anthropometric Indices of Patients with Arterial Hypertension Against the Background of Abdominal Obesity

The aim of our study was to investigate the dependence of carbohydrate metabolism in patients with arterial hypertension and concomitant abdominal obesity depending on Pro197Leu polymorphism of the GPX1 gene. Pro197Leu p...

Prognostic Value of Proteolysis Indexes in the Formation of Diabetic Retinopathy

The article presents the results of the study on the violations in the proteolysis system of patients with type 2 diabetes mellitus (DM) and diabetic retinopathy (DR). We have evaluated the levels of matrix metalloprotei...

A Case of Primary Hyperparathyroidism Combined with Cushing Syndrome due to Ectopic ACTH Secretion

A rare case of primary hyperparathyroidism (PHPT) combined with Cushing syndrome due to ectopic ACTH secretion in 37-year-old women is described. The patient gradually underwent surgeries after compensation of general co...

Role on мicroRNA for Diabetes Mellitus Development

The review presents a brief description of microRNA (miRNA), the mechanism of its formation and functioning. There are also analyzed literature data on miRNA role for diabetes mellitus development. There is generalized t...

Download PDF file
  • EP ID EP201725
  • DOI -
  • Views 54
  • Downloads 0

How To Cite

V. I. Pankivn (2016). Studying the Efficacy of Vazonat in Comprehensive Treatment of Patients with Diabetes Mellitus Type 2. Міжнародний ендокринологічний журнал, 4(76), 80-84. https://europub.co.uk/articles/-A-201725